SoRI-9804
SoRI-9804 is a pharmacological agent that is classified as a sigma receptor antagonist. It is primarily used in scientific research to study the role of sigma receptors in the body and their potential therapeutic applications.
Pharmacology[edit | edit source]
SoRI-9804 is a selective antagonist of the sigma-1 receptor, a protein that is widely distributed in the central nervous system and peripheral tissues. Sigma-1 receptors are involved in a variety of physiological processes, including the regulation of neurotransmitter release, cell proliferation, and cell survival.
SoRI-9804 binds to sigma-1 receptors and blocks their activity, which can be useful in studying the effects of these receptors in the body. It has been used in research to investigate the role of sigma-1 receptors in conditions such as schizophrenia, depression, and neurodegenerative diseases.
Research Applications[edit | edit source]
Research with SoRI-9804 has provided valuable insights into the potential therapeutic applications of sigma-1 receptor antagonists. For example, studies have suggested that these compounds could be used to treat neuropsychiatric disorders, pain, and certain types of cancer.
In addition, SoRI-9804 has been used to investigate the role of sigma-1 receptors in drug addiction. Some studies have suggested that sigma-1 receptor antagonists could be used to reduce the rewarding effects of addictive substances and to prevent relapse in individuals with substance use disorders.
Safety and Toxicology[edit | edit source]
As with any pharmacological agent, the safety and toxicity of SoRI-9804 must be carefully evaluated. While it is generally well-tolerated in laboratory animals, potential side effects and toxicities in humans are not fully understood. Therefore, further research is needed to determine the safety profile of SoRI-9804 and other sigma-1 receptor antagonists.
See Also[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
